Aurinia Pharmaceuticals Inc.
AUPH
$0.09
Change (1 day)
$9.74
Year High
$4.71
Year Low
Categories
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.
Stock split history for Aurinia Pharmaceuticals Inc. (AUPH)
Aurinia Pharmaceuticals Inc. stock (symbol: AUPH) underwent a total of 1 stock splits.
The most recent stock split occured on Oct 23, 2013.
Annual Revenue
| Date | Splite | Multiple |
|---|---|---|
| 2013-10-23 | 1:50 | 1 |